Torrent Pharmaceuticals Reports Strong Financial Results, Highlighting Operational Efficiency and Sales Growth in March 2025
Torrent Pharmaceuticals has announced its financial results for the quarter ending March 2025, revealing strong performance across key metrics. The company achieved its highest operating profit to interest ratio and net sales in five quarters, alongside significant improvements in operating profit and profit margins, indicating enhanced operational efficiency.
Torrent Pharmaceuticals has reported its financial results for the quarter ending March 2025, showcasing a notable performance in various key metrics. The company's score has undergone an adjustment in evaluation, reflecting a shift from 11 to 13 over the past three months.The financial data indicates that Torrent Pharma achieved its highest operating profit to interest ratio at 17.21 times, demonstrating an enhanced capacity to manage interest payments effectively. Additionally, net sales reached Rs 2,959.00 crore, marking the highest figure in the last five quarters, suggesting a favorable near-term sales trend.
Operating profit, measured as PBDIT, also peaked at Rs 964.00 crore, indicating a positive trajectory in operational efficiency. The operating profit margin improved to 32.58%, further underscoring the company's enhanced efficiency. Furthermore, profit before tax, excluding other income, was recorded at Rs 707.00 crore, the highest in the last five quarters, alongside a profit after tax of Rs 515.97 crore, which also reflects a positive trend.
These results highlight the underlying strengths within Torrent Pharmaceuticals as it navigates the competitive landscape of the pharmaceuticals and biotechnology industry.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
